ArticleBMC women's health2025
Human papillomavirus awareness and vaccination willingness among adults in Madagascar: a cross-sectional study.
Article in BMC women's health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Moving Beyond the Female-Only Paradigm: Arguments for Accelerating the Global Gender-Neutral Human Papillomavirus Vaccination.Cancer control : journal of the Moffitt Cancer CenterArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Disease awareness is key to utilising healthcare services, including vaccinations. Madagascar, with high human papillomavirus (HPV) prevalence (> 36%), marked cervical cancer rates, and low general routine vaccination coverage, faces major challenges in managing HPV-related diseases, mostly because of its fragile health system and the absence of HPV vaccination programmes. This study aimed to assess HPV awareness and vaccination willingness in Madagascar to inform strategies for implementing HPV vaccination programmes in the country. A cross-sectional survey among adults was conducted in the Boeny and Matsiatra Ambony regions. HPV awareness and willingness to be vaccinated against HPV were analysed using Poisson regression. Overall, the level of HPV awareness was low (4.6%; 95% CI: 3.8-5.6). Urban residency (aPR = 1.7; 95% CI: 1.1-2.6), higher education (aPR = 2.1; 95% CI: 1.1-4.0), and recent contact with healthcare services (aPR = 1.8; 95% CI: 1.2-2.6) were associated with greater HPV awareness. HPV vaccination willingness was generally high (67.0%; 95% CI: 65.0-69.0) but was significantly higher among participants aware of HPV (aPR = 1.4; 95% CI: 1.2-1.5). Most participants received ample information on general routine vaccinations, with healthcare workers (HCWs) reported as the most reliable source of information (48.6%). This study shows that improving knowledge about HPV could increase the success of HPV vaccination programmes in the country. In addition, the study highlights the importance of education in terms of health literacy, stressing that efforts to reach rural populations with lower levels of education are crucial.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.